Psoriatic Arthritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ACELYRIN, INC. Announces Magnitude of Clinical Responses with Izokibep in Psoriatic Arthritis Continues to Improve with Longer Duration of Therapy
LOS ANGELES, April 11, 2023. ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced long-term 46-week data from a global Phase 2 trial... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 11, 2023 Category: Pharmaceuticals Source Type: clinical trials

Arthroscopic synovectomy versus intra-articular injection of corticosteroids for the management of refractory psoriatic or rheumatoid arthritis of the wrist: study protocol for a randomized controlled trial (ARCTIC trial)
DiscussionPersistent wrist arthritis continues to be a problem for patients with rheumatic joint disease leading to disability. This is the first randomized controlled trial to evaluate the effect, safety and feasibility of arthroscopic synovectomy of the wrist in these patients compared to IACSI.Trial registrationDutch trial registry (CCMO), NL74744.100.20. Registered on 30 November 2020.ClinicalTrials.gov NCT04755127. Registered after the start of inclusion on 15 February 2021. (Source: Trials)
Source: Trials - March 25, 2023 Category: Research Source Type: clinical trials

RAFTLIN-1 Levels in Axial Spondyloarthritis and Psoriatic Arthritis
Conditions: Axial Spondyloarthritis; Psoriatic Arthritis Intervention: Diagnostic Test: serum raftlin-1 protein levels Sponsor: Bezmialem Vakif University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2023 Category: Research Source Type: clinical trials